1. Mirhosseini S, Dadgari A, Basirinezhad M, et al. The proportion of death anxiety and its related factors during the COVID-19 pandemic in the Iranian population. Fam Med Prim Care Rev 2021; 23(1): 36–40.
2.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507–513.
3.
Jing W, Zhao S, Liu J, et al. ABO blood groups and hepatitis B virus infection: A systematic review and meta-analysis. BMJ Open 2020; 10: e034114.
4.
Kaidarova Z, Bravo MD, Kamel HT, et al. Blood group A and D negativity are associated with symptomatic West Nile virus infection. Transfusion 2016; 56(7): 1699–1706.
5.
Pourhassan A. Association between ABO blood/rhesus grouping and hepatitis B and C: a case-control study. Pak J Biol Sci 2014; 17(6): 868–871.
6.
Czakó R, Atmar RL, Opekun AR, et al. Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol 2012; 19(2): 284–287.
7.
Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev 2015; 28(3): 801–870.
8.
Fujitani N, Liu Y, Okamura T, et al. Distribution of H type 1–4 chains of the ABO (H) system in different cell types of human respiratory epithelium. J Histochem Cytochem 2000; 48(12): 1649–1655.
9.
Gassó P, Ritter MA, Mas S, et al. Influence of ABO genotype and phenotype on angiotensin-converting enzyme plasma activity. J Renin-Angiotensin-Aldosterone Syst 2014; 15(4): 580–584.
10.
Cheng Y, Cheng G, Chui CH, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA 2005; 293(12): 1447–1451.
11.
Fan Q, Zhang W, Li B, et al. Association between ABO blood group system and COVID-19 susceptibility in Wuhan. Front Cell Infect Microbiol 2020; 10: 404.
12.
World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. Geneva: WHO; 2020.
13.
Wu BB, Gu DZ, Yu JN, et al. Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis. Infect Genet Evol 2020; 84: 104485.
14.
Bullerdiek J. Blood type A associated with critical COVID-19 and death in a Swedish cohort – a critical comment. Crit Care 2020; 24(1): 1–2.
15.
Leaf RK, Al-Samkari H, Brenner SK, et al. ABO phenotype and death in critically ill patients with COVID-19. Br J Haematol 2020; 190(4): e204–e248.
16.
Guillon P, Clément M, Sébille V, et al. Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology 2008; 18(12): 1085–1093.
17.
Chen L, Hao G. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. Cardiovasc Res 2020; 116(12): 1932–1936.
18.
Wan Y, Shang J, Graham R, et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol 2020; 94(7): 1–9.
19.
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224): 565–574.
20.
Dai X. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. Eur J Prev Cardiol 2020; 27(13): 1436–1437.
21.
Ray JG, Schull MJ, Vermeulen MJ, et al. Association between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness. Ann Intern Med 2020; 174(3): 308–315.
22.
Latz CA, DeCarlo C, Boitano L, et al. Blood type and outcomes in patients with COVID-19. Ann Hematol 2020; 99(9): 2113–2118.
